EdgarLookup

RADIAN GROUP INC — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that RADIAN GROUP INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
51.5%
Profit Margin
Net income ÷ revenue
1.9%
Return on Assets
Net income ÷ assets
0.7x
Debt-to-Equity
Total liabilities ÷ equity
-0.9%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $300.51M Feb 20, 2026
FY2025 Sep 30, 2025 $303.19M Feb 20, 2026
FY2025 Jun 30, 2025 $298.55M Feb 20, 2026
FY2025 Mar 31, 2025 $294.84M Feb 20, 2026
FY2025 Dec 31, 2024 $292.67M Feb 20, 2026
FY2025 Sep 30, 2024 $313.38M Feb 20, 2026
FY2025 Jun 30, 2024 $298.58M Feb 20, 2026
FY2025 Mar 31, 2024 $301.67M Feb 20, 2026
FY2025 Dec 31, 2023 $1.18B Feb 20, 2026
FY2024 Dec 31, 2022 $1.19B Feb 14, 2025

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $154.84M Feb 20, 2026
FY2025 Sep 30, 2025 $141.44M Feb 20, 2026
FY2025 Jun 30, 2025 $141.80M Feb 20, 2026
FY2025 Mar 31, 2025 $144.56M Feb 20, 2026
FY2025 Dec 31, 2024 $148.29M Feb 20, 2026
FY2025 Sep 30, 2024 $151.89M Feb 20, 2026
FY2025 Jun 30, 2024 $151.90M Feb 20, 2026
FY2025 Mar 31, 2024 $152.35M Feb 20, 2026
FY2025 Dec 31, 2023 $603.12M Feb 20, 2026
FY2024 Dec 31, 2022 $742.93M Feb 14, 2025

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2013 Dec 31, 2013 ($207.06M) Feb 28, 2014
FY2013 Dec 31, 2012 ($444.20M) Feb 28, 2014
FY2013 Dec 31, 2011 $368.51M Feb 28, 2014
FY2012 Dec 31, 2010 ($1.58B) Feb 22, 2013
FY2011 Dec 31, 2009 ($242.28M) Mar 2, 2012

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $119.86M Feb 20, 2026
FY2025 Dec 31, 2024 ($663.57M) Feb 20, 2026
FY2025 Dec 31, 2023 $529.43M Feb 20, 2026
FY2024 Dec 31, 2022 $388.30M Feb 14, 2025
FY2023 Dec 31, 2021 $557.11M Feb 23, 2024
FY2022 Dec 31, 2020 $658.43M Feb 24, 2023
FY2021 Dec 31, 2019 $694.43M Feb 25, 2022
FY2020 Dec 31, 2018 $677.79M Feb 26, 2021
FY2019 Dec 31, 2017 $360.58M Feb 28, 2020
FY2017 Dec 31, 2016 $381.72M Feb 28, 2018

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $8.12B Feb 20, 2026
FY2025 Dec 31, 2024 $8.69B Feb 20, 2026
FY2024 Dec 31, 2023 $7.59B Feb 14, 2025
FY2023 Dec 31, 2022 $7.06B Feb 23, 2024
FY2022 Dec 31, 2021 $7.84B Feb 24, 2023
FY2021 Dec 31, 2020 $7.95B Feb 25, 2022
FY2020 Dec 31, 2019 $6.81B Feb 26, 2021
FY2019 Dec 31, 2018 $6.31B Feb 28, 2020
FY2018 Dec 31, 2017 $5.90B Feb 28, 2019
FY2017 Dec 31, 2016 $5.86B Feb 28, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.34B Feb 20, 2026
FY2025 Dec 31, 2024 $4.07B Feb 20, 2026
FY2024 Dec 31, 2023 $3.20B Feb 14, 2025
FY2023 Dec 31, 2022 $3.14B Feb 23, 2024
FY2022 Dec 31, 2021 $3.58B Feb 24, 2023
FY2021 Dec 31, 2020 $3.66B Feb 25, 2022
FY2020 Dec 31, 2019 $2.76B Feb 26, 2021
FY2019 Dec 31, 2018 $2.83B Feb 28, 2020
FY2018 Dec 31, 2017 $2.90B Feb 28, 2019
FY2017 Dec 31, 2016 $2.99B Feb 28, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $4.78B Feb 20, 2026
FY2025 Dec 31, 2024 $4.62B Feb 20, 2026
FY2025 Dec 31, 2023 $4.40B Feb 20, 2026
FY2024 Dec 31, 2022 $3.92B Feb 14, 2025
FY2023 Dec 31, 2021 $4.26B Feb 23, 2024
FY2022 Dec 31, 2020 $4.28B Feb 24, 2023
FY2021 Dec 31, 2019 $4.05B Feb 25, 2022
FY2019 Dec 31, 2018 $3.49B Feb 28, 2020
FY2018 Dec 31, 2017 $3.00B Feb 28, 2019
FY2017 Dec 31, 2016 $2.87B Feb 28, 2018

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2024 Dec 31, 2024 $0 Feb 14, 2025
FY2024 Dec 31, 2023 $0 Feb 14, 2025
FY2023 Dec 31, 2022 $9.80M Feb 23, 2024
FY2022 Dec 31, 2021 $9.80M Feb 24, 2023
FY2021 Dec 31, 2020 $9.80M Feb 25, 2022
FY2014 Dec 31, 2014 $191.93M Mar 2, 2015

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.13B Feb 20, 2026
FY2025 Dec 31, 2024 $4.70B Feb 20, 2026
FY2024 Dec 31, 2023 $4.24B Feb 14, 2025
FY2023 Dec 31, 2022 $3.79B Feb 23, 2024
FY2022 Dec 31, 2021 $3.18B Feb 24, 2023
FY2021 Dec 31, 2020 $2.68B Feb 25, 2022
FY2020 Dec 31, 2019 $2.39B Feb 26, 2021
FY2019 Dec 31, 2018 $1.72B Feb 28, 2020
FY2018 Dec 31, 2017 $1.12B Feb 28, 2019
FY2017 Dec 31, 2016 $997.89M Feb 28, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $24.83M Feb 20, 2026
FY2025 Dec 31, 2024 $19.22M Feb 20, 2026
FY2024 Dec 31, 2023 $19.00M Feb 14, 2025
FY2023 Dec 31, 2022 $56.18M Feb 23, 2024
FY2022 Dec 31, 2021 $151.15M Feb 24, 2023
FY2021 Dec 31, 2020 $87.92M Feb 25, 2022
FY2020 Dec 31, 2019 $92.73M Feb 26, 2021
FY2019 Dec 31, 2018 $95.39M Feb 28, 2020
FY2018 Dec 31, 2017 $80.57M Feb 28, 2019
FY2017 Dec 31, 2016 $52.15M Feb 28, 2018

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2017 Dec 31, 2017 $1.03B Feb 28, 2018
FY2017 Dec 31, 2016 $1.07B Feb 28, 2018
FY2016 Dec 31, 2015 $1.22B Feb 27, 2017
FY2015 Dec 31, 2014 $1.19B Feb 26, 2016
FY2014 Dec 31, 2013 $930.07M Mar 2, 2015
FY2013 Dec 31, 2012 $663.57M Feb 28, 2014
FY2012 Dec 31, 2011 $818.58M Feb 22, 2013
FY2011 Dec 31, 2010 $964.79M Mar 2, 2012

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 20, 2026
FY2025 Sep 30, 2025 1 Feb 20, 2026
FY2025 Jun 30, 2025 1 Feb 20, 2026
FY2025 Mar 31, 2025 0 Feb 20, 2026
FY2025 Dec 31, 2024 0 Feb 20, 2026
FY2025 Sep 30, 2024 1 Feb 20, 2026
FY2025 Jun 30, 2024 0 Feb 20, 2026
FY2025 Mar 31, 2024 0 Feb 20, 2026
FY2025 Dec 31, 2023 3 Feb 20, 2026
FY2024 Dec 31, 2022 4 Feb 14, 2025

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 1 Feb 20, 2026
FY2025 Sep 30, 2025 1 Feb 20, 2026
FY2025 Jun 30, 2025 1 Feb 20, 2026
FY2025 Mar 31, 2025 0 Feb 20, 2026
FY2025 Dec 31, 2024 0 Feb 20, 2026
FY2025 Sep 30, 2024 0 Feb 20, 2026
FY2025 Jun 30, 2024 0 Feb 20, 2026
FY2025 Mar 31, 2024 0 Feb 20, 2026
FY2025 Dec 31, 2023 3 Feb 20, 2026
FY2024 Dec 31, 2022 4 Feb 14, 2025

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 135.50M Feb 20, 2026
FY2025 Dec 31, 2024 147.57M Feb 20, 2026
FY2025 Dec 31, 2023 153.18M Feb 20, 2026
FY2025 Dec 31, 2022 157.06M Feb 20, 2026
FY2024 Dec 31, 2021 175.42M Feb 14, 2025
FY2023 Dec 31, 2020 191.61M Feb 23, 2024
FY2022 Dec 31, 2019 201.16M Feb 24, 2023
FY2016 Dec 31, 2016 214.52M Feb 27, 2017
FY2016 Dec 31, 2015 206.87M Feb 27, 2017
FY2015 Dec 31, 2014 191.05M Feb 26, 2016

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $145.62M Feb 20, 2026
FY2025 Dec 31, 2024 $151.96M Feb 20, 2026
FY2025 Dec 31, 2023 $145.91M Feb 20, 2026
FY2024 Dec 31, 2022 $135.44M Feb 14, 2025
FY2023 Dec 31, 2021 $103.30M Feb 23, 2024
FY2022 Dec 31, 2020 $97.46M Feb 24, 2023
FY2021 Dec 31, 2019 $2.06M Feb 25, 2022
FY2020 Dec 31, 2018 $2.14M Feb 26, 2021
FY2019 Dec 31, 2017 $2.15M Feb 28, 2020
FY2018 Dec 31, 2016 $2.11M Feb 28, 2019